MARKET

VBIV

VBIV

Vbi Vaccines
NASDAQ
0.6650
-0.0012
-0.18%
After Hours: 0.6500 -0.015 -2.26% 16:08 10/02 EDT
OPEN
0.6800
PREV CLOSE
0.6662
HIGH
0.6900
LOW
0.6400
VOLUME
173.75K
TURNOVER
0
52 WEEK HIGH
22.80
52 WEEK LOW
0.5932
MARKET CAP
15.21M
P/E (TTM)
-0.0482
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at VBIV last week (0925-0929)?
Weekly Report · 1d ago
Why Sharps Technology Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga · 5d ago
VBI Vaccines To Advance Coronavirus Vaccine Program
NASDAQ · 5d ago
VBI Vaccines’ pan-coronavirus vaccine candidate produced broad protection against variants of concern
MarketWatch · 6d ago
Weekly Report: what happened at VBIV last week (0918-0922)?
Weekly Report · 09/25 09:53
Weekly Report: what happened at VBIV last week (0911-0915)?
Weekly Report · 09/18 09:50
Weekly Report: what happened at VBIV last week (0904-0908)?
Weekly Report · 09/11 09:50
VBI Vaccines gains after Phase 2 data for Hep B candidate
Seeking Alpha · 09/06 11:33
More
About VBIV
VBI Vaccines Inc. is a commercial stage biopharmaceutical company. Through its approach to virus-like particles (VLPs), including an enveloped VLP (eVLP) platform technology, The Company develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. The Company is focused on targeting and overcoming infectious diseases, including hepatitis B (HBV), COVID-19, and coronaviruses, and cytomegalovirus (CMV), as well as cancers, including glioblastoma (GBM). Its product pipeline includes an approved vaccine and multiple late- and early-stage investigational programs. PreHevbrio is its approved vaccine for hepatitis B. Its Prophylactic Candidates for corona virus disease include VBI-2901, VBI-2905, VBI-2902, and other. VBI-1501 is its Prophylactic Candidate for cytomegalovirus. VBI-2501 is its Prophylactic Candidate for Zika virus. VBI-2601 and VBI-1901 are the therapeutic candidates for HBV and GBM.

Webull offers kinds of VBI Vaccines Inc stock information, including NASDAQ:VBIV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VBIV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VBIV stock methods without spending real money on the virtual paper trading platform.